Uso de antipsicóticos y su asociación con enfermedad tromboembólica venosa en pacientes adultos
Barra lateral del artículo
Contenido principal del artículo
Downloads
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ. 2010; 341:c4245. DOI: https://doi.org/10.1136/bmj.c4245
Parkin L, Skegg DC, Herbison GP, et al. Psychotropic drugs and fatal pulmonary embolism. Pharmacoepidemiol Drug Saf. 2003; 12:647-52. DOI: https://doi.org/10.1002/pds.841
Wu CS, Lin CC, Chang CM, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry. 2013; 74:918-24. DOI: https://doi.org/10.4088/JCP.12m08117
Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013; 33:753-8. DOI: https://doi.org/10.1097/JCP.0b013e3182a412d5
Ishiguro C,Wang X, Li L, et al. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014; 23:1168-75. DOI: https://doi.org/10.1002/pds.3699
Ishioka M, Yasui-Furukori N, Sugawara N, et al. Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers. Neuropsychiatr Dis Treat. 2015; 11:477-84. DOI: https://doi.org/10.2147/NDT.S75176
Jönsson AK, Spigset O, Hägg S. Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management. CNS Drugs. 2012; 26:649-62. DOI: https://doi.org/10.2165/11633920-000000000-00000
Ferraris A, Szmulewicz AG, Vázquez FJ, et al. Antipsychotic Use among Adult Outpatients and Venous Thromboembolic Disease. A Retrospective Cohort Study. J Clin Psychopharmacol. 2017; 37(4):405-11. DOI: https://doi.org/10.1097/JCP.0000000000000738